Clinical Trials Sponsored by Cancer Research UK Cambridge Institute

Total 4624 results

Instituto Nacional de Cancer, Brazil
Cancer Research UK Cambridge Institute

Unknown

A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer (MEGA)

Breast Neoplasm

Brazil
University of Cambridge
Cancer Research UK

Not yet recruiting

How Does Skin Tone Affect Quantitative Photoacoustic Imaging (PAISKINTONE)

Skin Abnormalities | Vitiligo
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge; Cancer Research UK Cambridge Institute

Completed

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer (EVIS)

Pancreatic Cancer

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
AstraZeneca; Cancer Research UK Cambridge Institute

Recruiting

DLBCL Interim Response Evaluation for Customised Therapy (DIRECT)

High-grade B-cell Lymphoma

United Kingdom
University of Cambridge
Medical Research Council; Cancer Research UK

Active, not recruiting

The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study (EPIC-Norfolk)

Cardiovascular Diseases | Neoplasms | Death
Cambridge University Hospitals NHS Foundation Trust
AstraZeneca; Cancer Research UK

Recruiting

Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer (PARTNER)

Breast Cancer

United Kingdom
Cancer Research UK

Completed

Phase I Study of MOv18 IgE

Human Cancers

United Kingdom
Cancer Research UK

Completed

AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

United Kingdom
Cancer Research UK

Completed

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Relapsed or Refractory Neuroblastoma

United Kingdom
Cancer Research UK

Completed

AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific

United Kingdom
Cancer Research UK

Terminated

A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours (AZD0424)

Advanced Solid Tumours

United Kingdom
Cancer Research UK

Terminated

NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Cancer Research UK

Terminated

GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Cancer Research UK

Completed

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Lymphoma | Head and Neck Cancer | Gastric Cancer | Nonneoplastic Condition | Lymphoproliferative Disorder

United Kingdom
Cancer Research UK

Withdrawn

Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer

Prostate Cancer

United Kingdom
CCTU- Cancer Theme
AstraZeneca; Cancer Research UK; University of Cambridge

Recruiting

WIRE - Novel Treatments in Renal Cell Cancer (WIRE)

Renal Cell Cancer

United Kingdom
Cancer Research UK

Terminated

AMG 319 in HPV Positive and Negative HNSCC

Human Papillomavirus (HPV) | Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx

United Kingdom
Cancer Research UK

Completed

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Brain and Central Nervous System Tumors

United Kingdom
Cancer Research UK

Completed

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Breast Cancer

United Kingdom
Cancer Research UK

Completed

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Breast Cancer | Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United Kingdom
Cancer Research UK

Completed

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

Leukemia

United Kingdom
Cancer Research UK

Completed

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

Neoplasms | Lymphoma | Cancer | B-Cell | Non-Hodgkin

United Kingdom
Cancer Research UK

Terminated

Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United Kingdom
Cancer Research UK

Terminated

Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer

Prostate Cancer

United Kingdom
Cancer Research UK

Terminated

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Cancer Research UK

Active, not recruiting

A CR-UK Phase I Trial of LY3143921

a. Colorectal Cancer | b. High Grade Serous Ovarian Cancer | c. Non Small-cell Lung Cancer (Squamous Cell Variant) | d. Squamous Carcinoma of the Oesophagus | e. Squamous Carcinoma of the Head and Neck (HPV Negative) | f. Urothelial Cancer | g. Breast Cancer (Triple Negative Type) | h. Pancreatic...

United Kingdom
Cancer Research UK

Completed

A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma

Metastatic Neuroblastoma

United Kingdom
Cancer Research UK

Completed

Phase I Study of AT13148, a Novel AGC Kinase Inhibitor

Advanced Solid Tumours

United Kingdom
Cancer Research UK

Completed

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Nasopharyngeal Cancer | Epstein Barr Virus Infections

United Kingdom
Cancer Research UK

Completed

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Chronic Lymphocytic Leukaemia | Indolent B-cell Lymphoma | Waldenström Macroglobulinaemia

United Kingdom
Cancer Research UK

Completed

MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic Cancer

United Kingdom
Cancer Research UK

Completed

Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Papworth Hospital NHS Foundation Trust
Cancer Research UK; University of Cambridge

Recruiting

Second Primary Lung Cancer Cohort Study (SPORT) (SPORT)

Lung Cancer

United Kingdom
Owlstone Ltd
Cambridge University Hospitals NHS Foundation Trust; Cancer Research UK

Completed

PAN-study: Pan-Cancer Early Detection Study (PAN)

Gastric Cancer | Esophageal Cancer | Liver Cancer

United Kingdom
Cancer Research UK
Vaccitech (UK) Limited

Recruiting

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Non-small Cell Lung Cancer (NSCLC)

United Kingdom
Cancer Research UK

Unknown

Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom

Healthy, no Evidence of Disease

United Kingdom
Cancer Research UK

Unknown

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

Lymphoma | Small Intestine Cancer

United Kingdom
Cancer Research UK

Unknown

Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom

Prostate Cancer

United Kingdom
Cancer Research UK

Unknown

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Lymphoma | Kidney Cancer | Pancreatic Cancer | Esophageal Cancer | Brain and Central Nervous System Tumors | Bladder Cancer | Intraocular Melanoma | Melanoma (Skin) | Transitional Cell Cancer of the Renal Pelvis and Ureter

United Kingdom
Cancer Research UK

Unknown

Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom

Breast Cancer

United Kingdom
Cancer Research UK

Unknown

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Lymphoma | Small Intestine Cancer

United Kingdom
Cancer Research UK

Unknown

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Breast Cancer

United Kingdom, Belgium
Cancer Research UK

Unknown

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Lymphoma
Cancer Research UK

Terminated

Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United Kingdom
Cancer Research UK

Terminated

Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer

Breast Cancer

United Kingdom
Cancer Research UK

Completed

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

Pain | Prostate Cancer | Metastatic Cancer

United Kingdom
Cancer Research UK

Completed

Geldanamycin Analogue in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Cancer Research UK

Completed

Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression

Unspecified Adult Solid Tumor, Protocol Specific | Spinal Cord Compression

United Kingdom
Cancer Research UK

Unknown

Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

Lymphoma

United Kingdom
Cancer Research UK

Unknown

Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends

Breast Cancer

United Kingdom

Clinical Trials Sponsored by Cancer Research UK Cambridge Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations